Non-vegetarian N-111 group. for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Indian Institute of Research, Mumbai, India
Breast Cancer+1 More
Dietary Supplement: N-111 - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The study will look at the end result of 2 types of diets effect on treatment outcome of cancer patients using N-111.

Eligible Conditions

  • Breast Cancer
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: End of month 3.

End of month 3.
Active Comparator: Non-vegetarian N-111 group.
Active Comparator: Vegetarian N-111 group
Placebo Comparator: Non-vegetarian placebo control group
Placebo Comparator: Vegetarian placebo group

Trial Safety

Safety Progress

1 of 3

Trial Design

6 Treatment Groups

Vegetarian control group
1 of 6
Non-vegetarian control group
1 of 6
Non-vegetarian N-111 group.
1 of 6
Vegetarian N-111 group
1 of 6
Non-vegetarian placebo control group
1 of 6
Vegetarian placebo group
1 of 6
Active Control
Non-Treatment Group

160 Total Participants · 6 Treatment Groups

Primary Treatment: Non-vegetarian N-111 group. · Has Placebo Group · Phase 1

Non-vegetarian placebo control group
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Vegetarian control groupNoIntervention Group · 1 Intervention: Vegetarian control group · Intervention Types:
Non-vegetarian control groupNoIntervention Group · 1 Intervention: Non-vegetarian control group · Intervention Types:
Vegetarian placebo group
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Non-vegetarian N-111 group.
DietarySupplement
ActiveComparator Group · 1 Intervention: Dietary Supplement: N-111 · Intervention Types: DietarySupplement
Vegetarian N-111 group
DietarySupplement
ActiveComparator Group · 1 Intervention: Dietary Supplement: N-111 · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: end of month 3.
Closest Location: Optimal Health Research · Salt Lake City, UT
Photo of Salt Lake City 1Photo of Salt Lake City 2Photo of Salt Lake City 3
2018First Recorded Clinical Trial
2 TrialsResearching Breast Cancer
6 CompletedClinical Trials

Who is running the clinical trial?

Optimal Health ResearchLead Sponsor
7 Previous Clinical Trials
635 Total Patients Enrolled
2 Trials studying Breast Cancer
150 Patients Enrolled for Breast Cancer
EA Jeppsen, MDStudy ChairOptimal Health Research
1 Previous Clinical Trials
90 Total Patients Enrolled
1 Trials studying Breast Cancer
90 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have prostate cancer as determined by a Transrectal Biopsy with associated Prostate-specific antigen blood work.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.